Extended-release hydrocodone (Zohydro ER) for pain

Medical Letter on Drugs and Therapeutics

Volumn 56, Issue 1444, 2014, Pages 45-46

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUTORPHANOL; BUTORPHANOL TARTRATE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN; HYDROCODONE; HYDROCODONE BITARTRATE; HYDROMORPHONE; MORPHINE; MORPHINE SULFATE; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PLACEBO;

CLINICAL TRIAL (TOPIC); CONSTIPATION; DIZZINESS; DRUG COST; DRUG RELEASE; FATIGUE; HEADACHE; HUMAN; LETTER; NAUSEA AND VOMITING; PAIN; PRURITUS; SOMNOLENCE; XEROSTOMIA;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; DELAYED-ACTION PREPARATIONS; DRUG APPROVAL; HUMANS; HYDROCODONE; PAIN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84903139447     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Drugs for pain. Treat Guidel Med Lett 2013; 11:31.
2. RL Rauck et al. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study. Pain Med 2014; Feb 12 (epub).
3. D Krashin et al. Extended-release hydrocodone-gift or curse? J Pain Res 2013; 6:53.
4. FDA Background Material-NDA 202880. Zohydro ER (hydrocodone) for the management of moderate to severe chronic pain. Meeting of the AADPAC, December 7, 2012. Available at www.fda. gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/ Drugs/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee/ ucm330683.pdf. Accessed May 29, 2014.
5. Y Olsen and JM Sharfstein. Chronic pain, addiction, and Zohydro. New Engl J Med 2014; 370:2061.
6. Inhibitors and inducers of CYP enzymes and P-glycoprotein. Med Lett Drugs Ther 2013; 55:e44.